Klára Marton, MD is the Business Development Director of Egis Pharmaceuticals PLC /owned by Servier/, one of the leading generic pharmaceutical companies in the CEE and CIS regions with activities extending from research and development, active ingredient and finished product pharmaceutical production to sales and marketing. Her priorities at Egis is leading international strategic business development, defining mid- and long-term pipeline consists of value-added products, commodity generics, biosimilar products, hard-to-make generics, products with intellectual property advantage, medical devices and digital patient solutions. She is also responsible for licensing-in and strategic partnerships. Under her leadership the early involvement of customer insight in business development, especially patient insight has been established. She is the Vice Chair of the Value Added Sector Group of Medicines for Europe, which represents pharmaceutical companies in Europe and is the voice of the generic, biosimilar and value added industries. Before Egis she worked as a Business Unit Director with responsibilities ranging from marketing, sales to market access covering several therapeutic fields (prescription products and media driven portfolio as well) at GSK, Sanofi-Aventis in Budapest. Earlier she held commercial positions at multinational innovative companies in Hungary and consulting company in the US. She is a Medical Doctor and holds a Master of Business Administration degree.